Shares of Liminatus Pharma rose after the company shared plans to collaborate on developing a diagnostic kit for detecting pancreatic cancer. The stock advanced 3.7%, to $9.35, in after-hours trading ...

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

A similarly gloomy simulation posted by Dr Paulien Moyaert back in May documented how being diagnosed with cancer can lead to ...

MRI-based screening has the potential for identifying early-stage pancreatic cancer in older adults with new onset or deteriorating diabetes, preliminary results show.

FULLERTON, CA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Liminatus Pharma today announced that it has entered into a Memorandum of Understanding (MOU) to form a research and development ...

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...

Imagine a routine blood donation quietly holding evidence of a future cancer diagnosis. A recent study published in Cancer ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

Additionally, lipid metabolism dysregulation can reshape the tumor microenvironment, aiding cancer cell survival and invasion. Furthermore, diabetes mellitus is intricately linked to pancreatic ...

This month, the FDA gave “Breakthrough Device Designation” to a new blood test by Guardian Health for detection of eight ...

One of the deadliest forms of the disease has survival rates as low as 25% for patients living for a year or more ...